Liang Chen, Zhanjun Lu, Dengfeng Kang, Zhongsheng Feng, Gengfeng Li, Mingming Sun, . . . Leilei Fang. (2022). Distinct alterations of fecal microbiota refer to the efficacy of adalimumab in Crohn's disease. Frontiers Media S.A..
Chicago Style (17th ed.) CitationLiang Chen, Zhanjun Lu, Dengfeng Kang, Zhongsheng Feng, Gengfeng Li, Mingming Sun, Zhanju Liu, Wei Wu, and Leilei Fang. Distinct Alterations of Fecal Microbiota Refer to the Efficacy of Adalimumab in Crohn's Disease. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationLiang Chen, et al. Distinct Alterations of Fecal Microbiota Refer to the Efficacy of Adalimumab in Crohn's Disease. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.